Clinical Trial Update: Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy and peripheral stem cell transplantation followed by immunotherapy in patients with leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Leukemia | Phase 2 | Status: COMPLETED